Why Northwest Biotherapeutics, Ballard Power Systems, and Plug Power Are Today's 3 Best Stocks

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

With no domestic economic news on the docket, the broad-based S&P 500 (SNPINDEX: ^GSPC  ) took its early cues from the Shanghai Composite which fell nearly 3% overnight following abysmal Chinese export data.

Overseas shipments from China dipped 18.1% in February, which looks even worse when compared to analyst forecasts for an expansion of 7.5%! The Chinese New Year certainly makes visibility difficult for economists sometimes, but we're talking about a better than 25% miss here that could signal the Chinese economy is weakening. That's not even in the ballpark, and it's one reason why the markets headed decisively lower in the early morning.

By day's end, however, the S&P 500 had recouped much of its losses as the situation in Ukraine, which is a daily geopolitical hot spot now, had not worsened, and what select earnings reports were out there trended toward better than expected.

The S&P 500 finished lower by just 0.87 points (-0.05%) to close at 1,877.17, which is much better than its earlier intraday low of 1,867.

One of the day's biggest gainers was small-cap clinical-stage biopharmaceutical company Northwest Biotherapeutics (NASDAQ: NWBO  ) , which gained 29.6% after Germany granted its experimental immunotherapy DCVax-L two special approvals. The first approval, from Germany's equivalent of the U.S. Food and Drug Administration, is a five-year-term "hospital exemption" that allows German hospitals to use DCVax-L in treating newly diagnosed and recurrent glioma brain cancers. This exemption will allow Northwest Biotherapeutics to charge full price for its treatment outside of its ongoing U.S. clinical trials.

In addition, the German reimbursement authority made DCVax-L eligible for health insurance reimbursement in the nation. A press release noted that six hospitals have applied for reimbursement eligibility thus far. This is clearly good news for Northwest Biotherapeutics and could go a long way toward validating its immunotherapy platform. However, I'd keep in mind that this is but one country, and its success in the U.S. via ongoing phase 3 studies is far more crucial. Investors should not get carried away by chasing today's news too much higher.

The S&P 500 standouts, though, once again were fuel-cell system developers Plug Power (NASDAQ: PLUG  ) , which gained 24.7%, and Ballard Power Systems (NASDAQ: BLDP  ) , which claimed top honors with a 30.3% daily gain. What's really interesting is that neither move had any company-specific news behind it today, with both stocks feeding off of optimism from last week.

For Plug Power, that continues to be the bullishness surrounding its order to supply 1,738 fuel-cell systems for forklifts in select Wal-Mart warehouses throughout the U.S. The thinking from investors here is that a large client such as Wal-Mart could open a number of doors for Plug Power to gain new contracts, and could even remove some of the lumpiness with its revenue stream that shareholders have become accustomed to over the years.

Ballard Power Systems shareholders seem most excited by the fact that nearly 5 million warrants were exercised last week related to two 2013 underwritten share offerings. These warrants helped to generate $7.6 million in additional funds for Ballard, which it can use for general corporate purposes, as well as research and development.

The key point to note here is that both Plug Power and Ballard Power Systems are losing money. Plug may have snagged itself an elephant in Wal-Mart, but with a $1.1 billion valuation and the expectation of perhaps $60 million in revenue in fiscal 2014, the move may be a bit excessive. The same could be said for Ballard Power which is closing in on an earnings-per-share breakeven point (likely by 2016), but is valued at close to eight times next year's revenue. This looks like a sector that could deflate any day.

Fuel-cell developers are soaring, but even they may be no match for this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (3) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 10, 2014, at 7:56 PM, jsss7789 wrote:

    Does Sean realize that PLUG is going to turn a profit this year?!?

    Statements like, "The key point to note here is that both Plug Power and Ballard Power Systems are losing money." makes me believe he either doesn't know much about PLUG or he has an agenda. Pretty sad stuff.....

  • Report this Comment On March 10, 2014, at 8:21 PM, confident wrote:

    Perhaps you missed this interview with the ceo on CNBC on Friday

  • Report this Comment On March 11, 2014, at 1:21 AM, goobobe wrote:

    once a smart , very expert top analyst,stock broker, named jim cramer said on one of his show that he liked to eat the borrito but not buy the stock of chipotle, after hearing from this so called the expert i sold my 300 shares at $60 with some small profit, now at $ 587.00 a shair mr, cramer is dancing from joy recommending the stock and bashing plug, go to hell cramer

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2871310, ~/Articles/ArticleHandler.aspx, 8/30/2015 10:14:40 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and in investment planning topics. You'll usually find him writing about Obamacare, marijuana, developing drugs, diagnostics, and medical devices, Social Security, taxes, or any number of other macroeconomic issues.

Today's Market

updated 1 day ago Sponsored by:
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 1.21 0.06%
NASD 4,828.33 15.62 0.32%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 4:55 PM
^GSPC $1988.87 Up +1.21 +0.06%
S&P 500 INDEX CAPS Rating: No stars
BLDP $1.28 Up +0.04 +3.23%
Ballard Power Syst… CAPS Rating: **
NWBO $8.11 Down -0.19 -2.29%
Northwest Biothera… CAPS Rating: *
PLUG $1.76 Up +0.01 +0.57%
Plug Power, Inc. CAPS Rating: *